Literature DB >> 1693468

Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles.

M L Schmidt1, V M Lee, J Q Trojanowski.   

Abstract

Neurofibrillary tangles (NFTs) derive, in part, from normal neuronal cytoskeletal proteins, ie, large portions of tau (tau) but only restricted segments of the peripheral domains of the high- and middle-molecular weight neurofilament subunits. To learn more about the events leading to the incorporation of tau and neurofilament epitopes into NFTs, the relative abundance of tau and NF determinants in these lesions was quantitatively analyzed in hippocampi from Alzheimer disease (AD) patients and age-matched controls using monoclonal antibodies specific for tau or for NF proteins. Immunostained NFTs appeared qualitatively the same in both AD and controls, ie, every epitope found in AD NFTs occurred also in the NFTs of the control patients. However, in hippocampi with only a few tangles, tau epitopes, but no NF epitopes, were detected in NFTs. In contrast, both tau and NF epitopes were present in those tangles that were found in hippocampi with abundant NFTs. Nevertheless, the number of tau-positive NFTs generally exceeded the number of NF-positive NFTs. These findings indicate that tau epitopes are more abundant than NF epitopes in NFTs and that the formation of NFTs may be linked to a derangement in the normal metabolism of tau that is more extensive than alterations in NF protein metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693468      PMCID: PMC1877428     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.

Authors:  C L Joachim; J H Morris; D J Selkoe; K S Kosik
Journal:  J Neuropathol Exp Neurol       Date:  1987-11       Impact factor: 3.685

2.  Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus.

Authors:  M L Schmidt; V M Lee; J Q Trojanowski
Journal:  Lab Invest       Date:  1989-04       Impact factor: 5.662

3.  Staining with monoclonal antibodies to neurofilaments distinguishes between subpopulations of neurofibrillary tangles, between groups of axons and between groups of dendrites.

Authors:  J Kahn; B H Anderton; C C Miller; J N Wood; M M Esiri
Journal:  J Neurol       Date:  1987-05       Impact factor: 4.849

4.  Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.

Authors:  N Nukina; K S Kosik; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens.

Authors:  M L Schmidt; R E Gur; R C Gur; J Q Trojanowski
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

6.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

Authors:  C M Wischik; M Novak; H C Thøgersen; P C Edwards; M J Runswick; R Jakes; J E Walker; C Milstein; M Roth; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Authors:  M Goedert; C M Wischik; R A Crowther; J E Walker; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.

Authors:  S C Papasozomenos
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

9.  Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.

Authors:  C Bancher; C Brunner; H Lassmann; H Budka; K Jellinger; G Wiche; F Seitelberger; I Grundke-Iqbal; K Iqbal; H M Wisniewski
Journal:  Brain Res       Date:  1989-01-16       Impact factor: 3.252

10.  Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles.

Authors:  H Ksiezak-Reding; D W Dickson; P Davies; S H Yen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more
  17 in total

1.  alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Authors:  Nigel J Cairns; Kunihiro Uryu; Eileen H Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Steven E Arnold; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2004-05-28       Impact factor: 17.088

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

3.  Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.

Authors:  M L Schmidt; V M Lee; M Forman; T S Chiu; J Q Trojanowski
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments.

Authors:  T Ishihara; M Higuchi; B Zhang; Y Yoshiyama; M Hong; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

5.  Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies.

Authors:  M L Schmidt; J Murray; V M Lee; W D Hill; A Wertkin; J Q Trojanowski
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

6.  Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.

Authors:  N J Cairns; M Grossman; S E Arnold; D J Burn; E Jaros; R H Perry; C Duyckaerts; B Stankoff; B Pillon; K Skullerud; F F Cruz-Sanchez; E H Bigio; I R A Mackenzie; M Gearing; J L Juncos; J D Glass; H Yokoo; Y Nakazato; S Mosaheb; J R Thorpe; K Uryu; V M-Y Lee; J Q Trojanowski
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

7.  Immunohistochemical markers for quantitative studies of neurons and glia in human neocortex.

Authors:  Lise Lyck; Ishar Dalmau; John Chemnitz; Bente Finsen; Henrik Daa Schrøder
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

Review 8.  Beta-amyloid deposition and the aging brain.

Authors:  Karen M Rodrigue; Kristen M Kennedy; Denise C Park
Journal:  Neuropsychol Rev       Date:  2009-11-12       Impact factor: 7.444

9.  Heat-induced immunoreactivity of tau protein in neocortical neurons of fire fatalities.

Authors:  Kazuhiko Kibayashi; Hideki Shojo
Journal:  Int J Legal Med       Date:  2003-07-09       Impact factor: 2.686

10.  Altered phosphorylation of tau protein in heat-shocked rats and patients with Alzheimer disease.

Authors:  S C Papasozomenos; Y Su
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.